Jones Hill Capital LP: ARCUTIS BIOTHERAPEUTICS INC (ARQT): Quarterly 13F Position History
As of Q2 2026, Jones Hill Capital LP reported 1,089,701 shares of ARCUTIS BIOTHERAPEUTICS INC (ARQT), worth $28.6M and representing 6.1% of its 13F equity book. The position first appeared in Q2 2026 and has been disclosed across 1 13F-HR filing in Pactolio's tracked window.
- 1,089,701Shares Held (Latest Filing)
- $28.6MReported Market Value (Latest Filing)
- 6.1%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- $0Quarter-over-Quarter Value Change
- 1,089,701Peak Reported Shares (Historical)
Recent initiation: Jones Hill Capital LP first reported ARQT on the Q2 2026 filing, so fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 1 quarter
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,089,701 | – | – | $28.6M | 6.1% | $26.2 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Jones Hill Capital LP first disclose a ARQT position in 13F-HR filings?
Jones Hill Capital LP first reported ARCUTIS BIOTHERAPEUTICS INC (ARQT) on its 13F-HR filing for the period ending 2026-06-30 (Q2 2026). The position has appeared on 1 reported quarter within Pactolio's tracked window.
What was Jones Hill Capital LP's most recent quarter-over-quarter share-count change in ARQT?
Jones Hill Capital LP reported 1,089,701 shares of ARQT on the most recent 13F-HR filing (Q2 2026). Insufficient prior data for a quarter-over-quarter share-count comparison.
Does the implied price-per-share represent Jones Hill Capital LP's cost basis in ARQT?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.